drugset / Trial / NCT06785571
The Evaluation of the Effectiveness and Safety of Nalbuphine Hydrochloride Injection for Analgesia in ICU Patients: A Multicenter, Randomized, Single-blinded, Parallel, Two-step Trial
Phase 2/3
Recruiting
204 enrolled
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Yichang Humanwell Pharmaceutical Co., Ltd., China · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The analgesic effect of nalbuphine hydrochloride injection will be evaluated in a multicenter, randomized, single-blind, parallel, positive-controlled approach in two steps: step 1, to explore the optimal dosage of nalbuphine hydrochloride injection with 2 experimental arms and 1 positive control and step 2, to evaluate the effectiveness and safety of nalbuphine hydrochloride injection in mechanically ventilated ICU patients at a dosage determined in step 1 with the same positive control.
Timeline
- Start
- 2023-08-30
- Primary completion
- 2025-10-31
- Completion
- 2025-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydromorphone | Other / unclassified | 0.5 mg | — |
| Subject | Nalbuphine | Small molecule | 2 mg | — |